Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00305266 |
Date of registration:
|
20/03/2006 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Study of CIDP Patients During IVIG Treatment
|
Scientific title:
|
"Clinical Study of Intravenous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy" |
Date of first enrolment:
|
August 2005 |
Target sample size:
|
11 |
Recruitment status: |
Completed |
URL:
|
http://clinicaltrials.gov/show/NCT00305266 |
Study type:
|
Observational |
Study design:
|
Time Perspective: Prospective
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Denmark
| | | | | | | |
Contacts
|
Name:
|
Henning Andersen, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Aarhus University Hospital |
|
Name:
|
Johannes Jakobsen, professor |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Aarhus University Hospital |
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Motor and sensory dysfunction involving more than one limb.
- Electrodiagnostic study with signs of demyelination
Exclusion Criteria:
- Prior systemic allergic reaction to IVIG
- Severe systemic disease
- Other conditions associated with neuropathy (eg diabetes, lack of vitamin- B12)
- Pregnancy
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
|
Intervention(s)
|
Drug: intravenous gammaglobulin
|
Secondary ID(s)
|
EudraCT nr.: 2004-004357-26
|
2005-0018
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|